What are the Toxicological Implications of Treatments?
Various treatments have been employed to combat COVID-19, including Remdesivir, Dexamethasone, and monoclonal antibodies. Each of these treatments carries potential toxicities:
Remdesivir: This antiviral drug has been associated with liver toxicity and renal impairment in some patients. Dexamethasone: While effective in reducing inflammation, long-term use can lead to complications such as hyperglycemia, osteoporosis, and increased susceptibility to infections. Monoclonal Antibodies: These can cause infusion-related reactions and potential immune system dysregulation.
